Ï㽶ÊÓƵ

News

THE HILL TIMES | Personalized medicine is the future of health care

Published: 5 February 2019

It’s small wonder that buying drugs is expensive. The federal government is consulting on whether a national pharmacare program can reduce costs, while providing coverage to vulnerable populations. But there is a complementary avenue to be explored that promises to lower healthcare costs and revitalize Canada’s pharmaceutical industry—personalized medicine.

Op-ed by Philippe Gros, deputy vice-principal, research and innovation, Ï㽶ÊÓƵ, and Officer of the Order of Canada and Mark Lathrop, professor of Human Genetics, and director of the McGill and Genome Quebec Innovation Center.

Back to top